(pseudoephedrine hydrochloride and terfenadine)
Seldane-D is indicated for the relief of symptoms associated with seasonal allergic rhinitis such as sneezing, rhinorrhea, pruritus, lacrimation, and nasal congestion. It should be administered when both the antihistaminic properties of Seldane (terfenadine) and the nasal decongestant activity of pseudoephedrine hydrochloride are desired.
Seldane-D has not been studied for effectiveness in relieving symptoms of the common cold.
Adults and pediatric patients 12 years and older: one tablet swallowed whole, morning and night.
USE OF DOSES IN EXCESS OF ONE TABLET B.I.D. IS NOT RECOMMENDED BECAUSE OF THE INCREASED POTENTIAL FOR QT INTERVAL PROLONGATION AND ADVERSE CARDIAC EVENTS. USE OF SELDANE-D IN PATIENTS WITH SIGNIFICANT HEPATIC DYSFUNCTION AND IN PATIENTS TAKING KETOCONAZOLE, ITRACONAZOLE, CLARITHROMYCIN, ERYTHROMYCIN, OR TROLEANDOMYCIN IS CONTRAINDICATED.
(Removed from market 1998)
Seldane-D Tablets containing 60 mg of terfenadine and 10 mg of pseudoephedrine hydrochloride in an outer press-coat for immediate release and 110 mg of pseudoephedrine hydrochloride in an extended- release core.
Tablets are white to off-white, biconvex capsule-shaped; debossed "Seldane-D".
Store at controlled room temperature (59-86°F) (15-30°C). Protect from moisture.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
No information provided.
Read the Seldane D (pseudoephedrine hydrochloride, terfenadine (removed from market 1998)) Side Effects Center for a complete guide to possible side effects »